Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1.

Rebucci M, Sermeus A, Leonard E, Delaive E, Dieu M, Fransolet M, Arnould T, Michiels C.

Mol Cancer. 2015 Apr 8;14:79. doi: 10.1186/s12943-015-0349-6.

2.

Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.

Notte A, Rebucci M, Fransolet M, Roegiers E, Genin M, Tellier C, Watillon K, Fattaccioli A, Arnould T, Michiels C.

Int J Biochem Cell Biol. 2015 May;62:1-14. doi: 10.1016/j.biocel.2015.02.010. Epub 2015 Feb 24.

PMID:
25724736
3.

Differential effect of hypoxia on etoposide-induced DNA damage response and p53 regulation in different cell types.

Sermeus A, Rebucci M, Fransolet M, Flamant L, Desmet D, Delaive E, Arnould T, Michiels C.

J Cell Physiol. 2013 Dec;228(12):2365-76. doi: 10.1002/jcp.24409.

PMID:
23702906
4.

Molecular aspects of cancer cell resistance to chemotherapy.

Rebucci M, Michiels C.

Biochem Pharmacol. 2013 May 1;85(9):1219-26. doi: 10.1016/j.bcp.2013.02.017. Epub 2013 Feb 19. Review.

PMID:
23435357
5.

Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma.

Végran F, Rebucci M, Chevrier S, Cadouot M, Boidot R, Lizard-Nacol S.

PLoS One. 2013;8(1):e55103. doi: 10.1371/journal.pone.0055103. Epub 2013 Jan 24.

6.

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.

Rebucci M, Peixoto P, Dewitte A, Wattez N, De Nuncques MA, Rezvoy N, Vautravers-Dewas C, Buisine MP, Guerin E, Peyrat JP, Lartigau E, Lansiaux A.

Int J Oncol. 2011 Jan;38(1):189-200.

PMID:
21109940
7.

A new model of patient tumor-derived breast cancer xenografts for preclinical assays.

Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De Pinieux G, Judde JG, Rebucci M, Tran-Perennou C, Sastre-Garau X, Sigal-Zafrani B, Delattre O, Diéras V, Poupon MF.

Clin Cancer Res. 2007 Jul 1;13(13):3989-98.

8.

Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.

Judde JG, Rebucci M, Vogt N, de Cremoux P, Livartowski A, Chapelier A, Tran-Perennou C, Boye K, Defrance R, Poupon MF, Bras-Gonçalves RA.

Int J Cancer. 2007 Apr 1;120(7):1579-90.

9.

Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.

Végran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S.

Oncogene. 2007 Jan 11;26(2):290-7. Epub 2006 Jul 17.

PMID:
16847456

Supplemental Content

Loading ...
Support Center